The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nebulizers and Inhalers Market Research Report 2025
Synopsis
Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
The global Nebulizers and Inhalers market was valued at US$ 14010 million in 2023 and is anticipated to reach US$ 18040 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
This report aims to provide a comprehensive presentation of the global market for Nebulizers and Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nebulizers and Inhalers.
Report Scope
The Nebulizers and Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nebulizers and Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nebulizers and Inhalers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PARI GmbH
Omron
Drive DeVilbiss Healthcare
Philips Respironics
Yuwell
Leyi
Folee
Medel S.p.A
Briggs Healthcare
3A Health Care
Segment by Type
Nebulizers
Inhalers
Segment by Application
COPD
Cystic Fibrosis
Asthma
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nebulizers and Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nebulizers and Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
The global Nebulizers and Inhalers market was valued at US$ 14010 million in 2023 and is anticipated to reach US$ 18040 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
This report aims to provide a comprehensive presentation of the global market for Nebulizers and Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nebulizers and Inhalers.
Report Scope
The Nebulizers and Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nebulizers and Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nebulizers and Inhalers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PARI GmbH
Omron
Drive DeVilbiss Healthcare
Philips Respironics
Yuwell
Leyi
Folee
Medel S.p.A
Briggs Healthcare
3A Health Care
Segment by Type
Nebulizers
Inhalers
Segment by Application
COPD
Cystic Fibrosis
Asthma
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nebulizers and Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nebulizers and Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nebulizers and Inhalers Market Overview
1.1 Product Overview and Scope of Nebulizers and Inhalers
1.2 Nebulizers and Inhalers Segment by Type
1.2.1 Global Nebulizers and Inhalers Market Value Comparison by Type (2024-2030)
1.2.2 Nebulizers
1.2.3 Inhalers
1.3 Nebulizers and Inhalers Segment by Application
1.3.1 Global Nebulizers and Inhalers Market Value by Application: (2024-2030)
1.3.2 COPD
1.3.3 Cystic Fibrosis
1.3.4 Asthma
1.3.5 Others
1.4 Global Nebulizers and Inhalers Market Size Estimates and Forecasts
1.4.1 Global Nebulizers and Inhalers Revenue 2019-2030
1.4.2 Global Nebulizers and Inhalers Sales 2019-2030
1.4.3 Global Nebulizers and Inhalers Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nebulizers and Inhalers Market Competition by Manufacturers
2.1 Global Nebulizers and Inhalers Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nebulizers and Inhalers Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nebulizers and Inhalers Average Price by Manufacturers (2019-2024)
2.4 Global Nebulizers and Inhalers Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nebulizers and Inhalers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nebulizers and Inhalers, Product Type & Application
2.7 Nebulizers and Inhalers Market Competitive Situation and Trends
2.7.1 Nebulizers and Inhalers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nebulizers and Inhalers Players Market Share by Revenue
2.7.3 Global Nebulizers and Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nebulizers and Inhalers Retrospective Market Scenario by Region
3.1 Global Nebulizers and Inhalers Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nebulizers and Inhalers Global Nebulizers and Inhalers Sales by Region: 2019-2030
3.2.1 Global Nebulizers and Inhalers Sales by Region: 2019-2024
3.2.2 Global Nebulizers and Inhalers Sales by Region: 2025-2030
3.3 Global Nebulizers and Inhalers Global Nebulizers and Inhalers Revenue by Region: 2019-2030
3.3.1 Global Nebulizers and Inhalers Revenue by Region: 2019-2024
3.3.2 Global Nebulizers and Inhalers Revenue by Region: 2025-2030
3.4 North America Nebulizers and Inhalers Market Facts & Figures by Country
3.4.1 North America Nebulizers and Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nebulizers and Inhalers Sales by Country (2019-2030)
3.4.3 North America Nebulizers and Inhalers Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nebulizers and Inhalers Market Facts & Figures by Country
3.5.1 Europe Nebulizers and Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nebulizers and Inhalers Sales by Country (2019-2030)
3.5.3 Europe Nebulizers and Inhalers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nebulizers and Inhalers Market Facts & Figures by Country
3.6.1 Asia Pacific Nebulizers and Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nebulizers and Inhalers Sales by Country (2019-2030)
3.6.3 Asia Pacific Nebulizers and Inhalers Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nebulizers and Inhalers Market Facts & Figures by Country
3.7.1 Latin America Nebulizers and Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nebulizers and Inhalers Sales by Country (2019-2030)
3.7.3 Latin America Nebulizers and Inhalers Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nebulizers and Inhalers Market Facts & Figures by Country
3.8.1 Middle East and Africa Nebulizers and Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nebulizers and Inhalers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nebulizers and Inhalers Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nebulizers and Inhalers Sales by Type (2019-2030)
4.1.1 Global Nebulizers and Inhalers Sales by Type (2019-2024)
4.1.2 Global Nebulizers and Inhalers Sales by Type (2025-2030)
4.1.3 Global Nebulizers and Inhalers Sales Market Share by Type (2019-2030)
4.2 Global Nebulizers and Inhalers Revenue by Type (2019-2030)
4.2.1 Global Nebulizers and Inhalers Revenue by Type (2019-2024)
4.2.2 Global Nebulizers and Inhalers Revenue by Type (2025-2030)
4.2.3 Global Nebulizers and Inhalers Revenue Market Share by Type (2019-2030)
4.3 Global Nebulizers and Inhalers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nebulizers and Inhalers Sales by Application (2019-2030)
5.1.1 Global Nebulizers and Inhalers Sales by Application (2019-2024)
5.1.2 Global Nebulizers and Inhalers Sales by Application (2025-2030)
5.1.3 Global Nebulizers and Inhalers Sales Market Share by Application (2019-2030)
5.2 Global Nebulizers and Inhalers Revenue by Application (2019-2030)
5.2.1 Global Nebulizers and Inhalers Revenue by Application (2019-2024)
5.2.2 Global Nebulizers and Inhalers Revenue by Application (2025-2030)
5.2.3 Global Nebulizers and Inhalers Revenue Market Share by Application (2019-2030)
5.3 Global Nebulizers and Inhalers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 PARI GmbH
6.1.1 PARI GmbH Corporation Information
6.1.2 PARI GmbH Description and Business Overview
6.1.3 PARI GmbH Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 PARI GmbH Nebulizers and Inhalers Product Portfolio
6.1.5 PARI GmbH Recent Developments/Updates
6.2 Omron
6.2.1 Omron Corporation Information
6.2.2 Omron Description and Business Overview
6.2.3 Omron Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Omron Nebulizers and Inhalers Product Portfolio
6.2.5 Omron Recent Developments/Updates
6.3 Drive DeVilbiss Healthcare
6.3.1 Drive DeVilbiss Healthcare Corporation Information
6.3.2 Drive DeVilbiss Healthcare Description and Business Overview
6.3.3 Drive DeVilbiss Healthcare Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Drive DeVilbiss Healthcare Nebulizers and Inhalers Product Portfolio
6.3.5 Drive DeVilbiss Healthcare Recent Developments/Updates
6.4 Philips Respironics
6.4.1 Philips Respironics Corporation Information
6.4.2 Philips Respironics Description and Business Overview
6.4.3 Philips Respironics Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Philips Respironics Nebulizers and Inhalers Product Portfolio
6.4.5 Philips Respironics Recent Developments/Updates
6.5 Yuwell
6.5.1 Yuwell Corporation Information
6.5.2 Yuwell Description and Business Overview
6.5.3 Yuwell Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yuwell Nebulizers and Inhalers Product Portfolio
6.5.5 Yuwell Recent Developments/Updates
6.6 Leyi
6.6.1 Leyi Corporation Information
6.6.2 Leyi Description and Business Overview
6.6.3 Leyi Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Leyi Nebulizers and Inhalers Product Portfolio
6.6.5 Leyi Recent Developments/Updates
6.7 Folee
6.6.1 Folee Corporation Information
6.6.2 Folee Description and Business Overview
6.6.3 Folee Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Folee Nebulizers and Inhalers Product Portfolio
6.7.5 Folee Recent Developments/Updates
6.8 Medel S.p.A
6.8.1 Medel S.p.A Corporation Information
6.8.2 Medel S.p.A Description and Business Overview
6.8.3 Medel S.p.A Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medel S.p.A Nebulizers and Inhalers Product Portfolio
6.8.5 Medel S.p.A Recent Developments/Updates
6.9 Briggs Healthcare
6.9.1 Briggs Healthcare Corporation Information
6.9.2 Briggs Healthcare Description and Business Overview
6.9.3 Briggs Healthcare Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Briggs Healthcare Nebulizers and Inhalers Product Portfolio
6.9.5 Briggs Healthcare Recent Developments/Updates
6.10 3A Health Care
6.10.1 3A Health Care Corporation Information
6.10.2 3A Health Care Description and Business Overview
6.10.3 3A Health Care Nebulizers and Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.10.4 3A Health Care Nebulizers and Inhalers Product Portfolio
6.10.5 3A Health Care Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nebulizers and Inhalers Industry Chain Analysis
7.2 Nebulizers and Inhalers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nebulizers and Inhalers Production Mode & Process
7.4 Nebulizers and Inhalers Sales and Marketing
7.4.1 Nebulizers and Inhalers Sales Channels
7.4.2 Nebulizers and Inhalers Distributors
7.5 Nebulizers and Inhalers Customers
8 Nebulizers and Inhalers Market Dynamics
8.1 Nebulizers and Inhalers Industry Trends
8.2 Nebulizers and Inhalers Market Drivers
8.3 Nebulizers and Inhalers Market Challenges
8.4 Nebulizers and Inhalers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
